株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の眼用ドラッグデリバリー市場

Ocular Drug Delivery Market

発行 Progressive Markets Research 商品コード 649315
出版日 ページ情報 英文 165 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の眼用ドラッグデリバリー市場 Ocular Drug Delivery Market
出版日: 2018年04月01日 ページ情報: 英文 165 Pages
概要

当レポートでは、世界の眼用ドラッグデリバリー市場について調査し、市場の現状と成長予測、製品別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 市場概要

第2章 競合分析

  • 大手3社、5社の市場シェア
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会

第3章 地域別市場

  • 市場シェア
  • 市場収益
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第4章 製品別市場

  • 市場シェア
  • 市場収益
  • 目薬
  • 硝子体内注射
  • 眼内インサート
  • 眼内インプラント
  • in situゲル
  • その他

第5章 用途別市場

  • 市場シェア
  • 市場収益
  • 緑内障
  • 白内障
  • ドライアイ症候群
  • 黄斑変性
  • その他

第6章 エンドユーザー別市場

  • 市場シェア
  • 市場収益
  • 病院
  • 在宅医療
  • その他

第7章 製造業者プロファイル/分析

  • NOVARTIS INTERNATIONAL AG
  • ALIMERA SCIENCES, INC.
  • ALLERGAN PLC.
  • OASIS MEDICAL, INC.
  • CLEARSIDE BIOMEDICAL, INC.
  • EYEGATE PHARMACEUTICALS, INC.
  • F. HOFFMANN-LA ROCHE LTD.
  • JOHNSON & JOHNSON
  • OCULAR THERAPEUTIX, INC.
  • VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

第8章 製造コスト分析

  • 主な原材料分析
  • 製造プロセス分析

第9章 業界チェーン、調達戦略、下流バイヤー

  • 業界チェーン分析
  • 上流原材料調達
  • 原材料入手源
  • 下流バイヤー

第10章 マーケティング戦略分析と流通業者/取引業者

  • マーケティングチャネル
  • マーケティングポジショニング
  • 流通業者/取引業者リスト

第11章 市場影響因子分析

  • 技術進歩/リスク

第12章 市場予測

  • 収益予測
  • 地域別市場予測
  • 製品タイプ別市場予測
  • 用途別市場予測
  • エンドユーザー別市場予測

第13章 調査結果と結論

第14章 調査方法とデータソース

目次
Product Code: PMR16559

Ocular Drug Delivery Market Overall Industry Analysis 2025

The global ocular drug delivery market was valued at $17,364 million in 2013, and is anticipated to reach $48,103 million by 2025, growing at a CAGR of 8.4% from 2018 to 2025.

Ocular drug delivery refers to the approaches used for transporting a pharmaceutical compound in the eye to safely achieve its desired therapeutic effect. The two major ocular drug delivery approaches used include topical and intraocular drug delivery methods. More than 60% of the eye dosage formulations available in the market are in the form of eye drops and ointments. However, these drops and ointments get drained from the ocular cavity, which fuels the need for advanced pharmaceutical ophthalmic formulations. These advanced formulations are available in the form of in-situ gels, nanoparticles, liposomes, iontophoresis, and ocular inserts.

The global ocular drug delivery market is segmented based on product, application, end user, and region. On the basis of product, the market is categorized into eye drops, ocular inserts, intraocular implants, in situ gels, and others. The applications covered in the study include glaucoma, diabetic retinopathy & macular edema, cataract, dry eye syndrome, macular degeneration, and others. Based on end user, the market is classified into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

Market dynamics

Drivers

  • Surge in demand for advanced ocular drug delivery approaches
  • Increase in prevalence rate of ocular disorders
  • Rise in R&D activities to develop advanced ocular drug delivery systems

Restraint

  • Poor demand for ocular drug delivery systems in underdeveloped countries

Opportunity

  • Growth opportunities in the emerging economies

Market players

The major players profiled in the report include: Alcon, Inc. (Novartis AG), Alimera Sciences, Inc., Allergan plc. (A Actavis plc.), Bausch & Lomb Inc. (A Valeant Pharmaceuticals International, Inc.), Clearside Biomedical, Inc., EyeGate Pharma, F. Hoffmann-La Roche Ltd., Johnson & Johnson Vision Care, Inc., OASIS Medical, Inc., and Ocular Therapeutix, Inc.

Market Landscape

By Product

  • Eye Drops
  • Intravitreal Injection
  • Ocular Inserts
  • Intraocular Implants
  • In Situ Gels
  • Others

By Application

  • Glaucoma
  • Diabetic Retinopathy & Macular Edema
  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Others

End User

  • Hospitals
  • Homecare Settings
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East
  • Africa

Table of Contents

PART 1. OCULAR DRUG DELIVERY MARKET OVERVIEW

  • 1.1. OCULAR DRUG DELIVERY PRODUCT OVERVIEW
  • 1.2. OCULAR DRUG DELIVERY SEGMENT BY PRODUCT TYPE
    • 1.2.1. Global Ocular Drug Delivery Sales and Growth (%)Comparison, By Product Type (2013-2025)
    • 1.2.2. Global Ocular Drug Delivery Sales Market Share (%) by Product Types in 2017
  • 1.3. OCULAR DRUG DELIVERY SEGMENT, BY APPLICATION
    • 1.3.1. Global Ocular Drug Delivery Sales and Growth (%) Comparison, By Application (2013-2025)
    • 1.3.2. Global Ocular Drug Delivery Sales Market Share (%) by Application in 2017
  • 1.4. OCULAR DRUG DELIVERY SEGMENT, BY END USER
    • 1.4.1. Global Ocular Drug Delivery Sales and Growth (%) Comparison, By End User (2013-2025)
    • 1.4.2. Global Ocular Drug Delivery Sales Market Share (%) by End User in 2017
  • 1.5. GLOBAL OCULAR DRUG DELIVERY MARKET BY REGION (2013-2025)
    • 1.5.1. Global Ocular Drug Delivery Market Size and Growth (%) Comparison by Regions (2013-2025)
    • 1.5.2. North America Ocular Drug Delivery Status and Prospect (2013-2025)
    • 1.5.3. Europe Ocular Drug Delivery Status and Prospect (2013-2025)
    • 1.5.4. Asia-Pacific Ocular Drug Delivery Status and Prospect (2013-2025)
    • 1.5.5. Latin America Ocular Drug Delivery Status and Prospect (2013-2025)
    • 1.5.6. Middle East and Africa Ocular Drug Delivery Status and Prospect (2013-2025)
  • 1.6. GLOBAL OCULAR DRUG DELIVERY MARKET SIZE (2013-2025)
    • 1.6.1. Global Ocular Drug Delivery Revenue ($Million) Status and Outlook (2013-2025)

PART 2. GLOBAL OCULAR DRUG DELIVERY MARKET COMPETITIVE ANALYSIS

  • 2.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%) OF TOP 3 AND TOP 5 MANUFACTURERS
  • 2.2. MARKET DYNAMICS
    • 2.2.1. Drivers
    • 2.2.2. Restraint
    • 2.2.3. Opportunity

PART 3. GLOBAL OCULAR DRUG DELIVERY MARKET, BY REGION

  • 3.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY REGION (2013-2018)
  • 3.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY REGION (2013-2018)
  • 3.3. NORTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
  • 3.4. EUROPE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
  • 3.5. ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
  • 3.6. LATIN AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)
  • 3.7. MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2013-2018)

PART 4. GLOBAL OCULAR DRUG DELIVERY MARKET, BY PRODUCT TYPE

  • 4.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY PRODUCT TYPE (2013-2018)
  • 4.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY PRODUCT TYPE (2013-2018)
  • 4.3. EYE DROPS MARKET REVENUE ($MILLION) (2013-2018)
  • 4.4. INTRAVITREAL INJECTIONS MARKET REVENUE ($MILLION) (2013-2018)
  • 4.5. OCULAR INSERTS MARKET REVENUE ($MILLION) (2013-2018)
  • 4.6. INTRAOCULAR IMPLANTS MARKET REVENUE ($MILLION) (2013-2018)
  • 4.7. IN SITU GELS MARKET REVENUE ($MILLION) (2013-2018)
  • 4.8. OTHER OCULAR DRUG DELIVERY PRODUCTS MARKET REVENUE ($MILLION) (2013-2018)

PART 5. GLOBAL OCULAR DRUG DELIVERY MARKET, BY APPLICATION

  • 5.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY APPLICATION (2013-2018)
  • 5.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY APPLICATION (2013-2018)
  • 5.3. OCULAR DRUG DELIVERY MARKET REVENUE FOR GLAUCOMA ($MILLION) (2013-2018)
  • 5.4. OCULAR DRUG DELIVERY MARKET REVENUE FOR DIABETIC RETINOPATHY & MACULAR EDEMA ($MILLION) (2013-2018)
  • 5.5. OCULAR DRUG DELIVERY MARKET REVENUE FOR CATARACT ($MILLION) (2013-2018)
  • 5.6. OCULAR DRUG DELIVERY MARKET REVENUE FOR DRY EYE SYNDROME ($MILLION) (2013-2018)
  • 5.7. OCULAR DRUG DELIVERY MARKET REVENUE FOR MACULAR DEGENERATION ($MILLION) (2013-2018)
  • 5.8. OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER APPLICATIONS ($MILLION) (2013-2018)

PART 6. GLOBAL OCULAR DRUG DELIVERY MARKET, BY END USER

  • 6.1. GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY END USER (2013-2018)
  • 6.2. GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY END USER (2013-2018)
  • 6.3. OCULAR DRUG DELIVERY MARKET REVENUE FOR HOSPITALS ($MILLION) (2013-2018)
  • 6.4. OCULAR DRUG DELIVERY MARKET REVENUE FOR HOMECARE SETTINGS ($MILLION) (2013-2018)
  • 6.5. OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER END USER ($MILLION) (2013-2018)

PART 7. GLOBAL OCULAR DRUG DELIVERY MANUFACTURERS PROFILES/ANALYSIS

  • 7.1. NOVARTIS INTERNATIONAL AG (ALCON INC.)
    • 7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.1.2. Novartis Ocular Drug Delivery Product Category
    • 7.1.3. Novartis Ocular Drug Delivery Revenue (Million USD)
    • 7.1.4. Main Business/Business Overview
  • 7.2. ALIMERA SCIENCES, INC.
    • 7.2.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.2.2. Alimera Ocular Drug Delivery Product Category
    • 7.2.3. Alimera Ocular Drug Delivery Revenue (Million USD)
    • 7.2.4. Main Business/Business Overview
  • 7.3. ALLERGAN PLC.
    • 7.3.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.3.2. Allergan Ocular Drug Delivery Product Category
    • 7.3.3. Allergan Ocular Drug Delivery Revenue (Million USD)
    • 7.3.4. Main Business/Business Overview
  • 7.4. OASIS MEDICAL, INC.
    • 7.4.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.4.2. OASIS Ocular Drug Delivery Product Category
    • 7.4.3. OASIS Ocular Drug Delivery Revenue (Million USD)
    • 7.4.4. Main Business/Business Overview
  • 7.5. CLEARSIDE BIOMEDICAL, INC.
    • 7.5.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.5.2. Clearside Ocular Drug Delivery Product Category
    • 7.5.3. Clearside Ocular Drug Delivery Revenue (Million USD)
    • 7.5.4. Main Business/Business Overview
  • 7.6. EYEGATE PHARMACEUTICALS, INC.
    • 7.6.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.6.2. EyeGate Ocular Drug Delivery Product Category
    • 7.6.3. EyeGate Ocular Drug Delivery Revenue (Million USD)
    • 7.6.4. Main Business/Business Overview
  • 7.7. F. HOFFMANN-LA ROCHE LTD.
    • 7.7.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.7.2. Roche Ocular Drug Delivery Product Category
    • 7.7.3. Roche Ocular Drug Delivery Revenue (Million USD)
    • 7.7.4. Main Business/Business Overview
  • 7.8. JOHNSON & JOHNSON (JOHNSON & JOHNSON VISION CARE, INC.)
    • 7.8.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.8.2. J&J Ocular Drug Delivery Product Category
    • 7.8.3. J&J Ocular Drug Delivery Revenue (Million USD)
    • 7.8.4. Main Business/Business Overview
  • 7.9. OCULAR THERAPEUTIX, INC.
    • 7.9.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.9.2. Ocular Therapeutix Ocular Drug Delivery Product Category
    • 7.9.3. asd Ocular Drug Delivery Revenue (Million USD)
    • 7.9.4. Main Business/Business Overview
  • 7.10. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (BAUSCH & LOMB INC.)
    • 7.10.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitor
    • 7.10.2. Valeant Ocular Drug Delivery Product Category
    • 7.10.3. Valeant Ocular Drug Delivery Revenue (Million USD)
    • 7.10.4. Main Business/Business Overview

PART 8. OCULAR DRUG DELIVERY MANUFACTURING COST ANALYSIS

  • 8.1. OCULAR DRUG DELIVERY KEY RAW MATERIALS ANALYSIS
    • 8.1.1. Key Raw Materials
    • 8.1.2. Key Suppliers of Raw Materials
  • 8.2. MANUFACTURING PROCESS ANALYSIS OF OCULAR DRUG DELIVERY

PART 9. INDUSTRIAL CHAIN, SOURCING STRATEGY, AND DOWNSTREAM BUYERS OF OCULAR DRUG DELIVERY MARKET

  • 9.1. OCULAR DRUG DELIVERY INDUSTRIAL CHAIN ANALYSIS
  • 9.2. UPSTREAM RAW MATERIALS SOURCING
  • 9.3. RAW MATERIAL SOURCES OF MAJOR OCULAR DRUG DELIVERY MANUFACTURERS
  • 9.4. DOWNSTREAM BUYERS

PART 10. MARKETING STRATEGY ANALYSIS AND DISTRIBUTORS/TRADERS

  • 10.1. MARKETING CHANNEL
    • 10.1.1. Direct Marketing
    • 10.1.2. Indirect Marketing
    • 10.1.3. Marketing Channel Development Trend
  • 10.2. MARKETING POSITIONING
    • 10.2.1. Pricing Strategy
    • 10.2.2. Brand Strategy
    • 10.2.3. Target client
  • 10.3. DISTRIBUTORS/TRADERS LIST

PART 11. MARKET EFFECT FACTORS ANALYSIS

  • 11.1. TECHNOLOGY PROGRESS/ RISK
    • 11.1.1. Substitutes Threat
    • 11.1.2. Technology Progress in Related Industry
    • 11.1.3. Consumer Needs/Customer Preference Change
    • 11.1.4. Economic/Political Environmental Change
    • 11.1.5. Exploration of new development opportunities, intellectual property, and potential acquisitions for external growth in the field of ophthalmic drug delivery

PART 12. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST (2018-2025)

  • 12.1. GLOBAL OCULAR DRUG DELIVERY REVENUE FORECAST ($MILLION) (2018-2025)
    • 12.1.1. Global Ocular Drug Delivery Revenue (Million USD) Forecast and Growth Rate (%) (2018-2025)
  • 12.2. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY REGION (2018-2025)
    • 12.2.1. North America Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
    • 12.2.2. EUROPE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
    • 12.2.3. ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
    • 12.2.4. SOUTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
    • 12.2.5. MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) (2018-2025)
  • 12.3. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY PRODUCT TYPE (2018-2025)
    • 12.3.1. Eye Drops Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
    • 12.3.2. Intravitreal Injections Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
    • 12.3.3. Ocular Inserts Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
    • 12.3.4. Intraocular Implants Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
    • 12.3.5. In Situ Gels Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
    • 12.3.6. Other Ocular Drug Delivery Products Market Revenue ($Million) Forecast and Growth Rate (%) (2018-2025)
  • 12.4. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY APPLICATION (2018-2025)
    • 12.4.1. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Glaucoma (2018-2025)
    • 12.4.2. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Diabetic Retinopathy & Macular Edema (2018-2025)
    • 12.4.3. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Cataract (2018-2025)
    • 12.4.4. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Dry Eye Syndrome (2018-2025)
    • 12.4.5. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Macular Degeneration (2018-2025)
    • 12.4.6. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Other Applications (2018-2025)
  • 12.5. GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST, BY END USER (2018-2025)
    • 12.5.1. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Hospitals (2018-2025)
    • 12.5.2. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Homecare Settings (2018-2025)
    • 12.5.3. Ocular Drug Delivery Market Revenue ($Million) Forecast and Growth Rate (%) For Other End User (2018-2025)

PART 13. RESEARCH FINDINGS AND CONCLUSION

PART 14. METHODOLOGY AND DATA SOURCE

  • 14.1. METHODOLOGY/RESEARCH APPROACH
    • 14.1.1. Research Programs/Design
    • 14.1.2. Market Size Estimation
    • 14.1.3. Market Breakdown and Data Triangulation
  • 14.2. DATA SOURCE
    • 14.2.1. Secondary sources
    • 14.2.2. Primary Sources

List of Tables

  • TABLE OCULAR DRUG DELIVERY SALES ($MILLION) AND GROWTH (%), COMPARISON BY PRODUCT TYPE, 2013-2025
  • TABLE OCULAR DRUG DELIVERY SALES ($MILLION) AND GROWTH (%), COMPARISON BY APPLICATION, 2013-2025
  • TABLE GLOBAL OCULAR DRUG DELIVERY SALES ($MILLION) AND GROWTH (%), COMPARISON BY END USER, 2013-2025
  • TABLE GLOBAL OCULAR DRUG DELIVERY SALES AND GROWTH (%), COMPARISON BY REGION, (2013-2025)
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY REGION, 2013-2018
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY REGION, 2013-2018
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY PRODUCT TYPE, 2013-2018
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY PRODUCT TYPE, 2013-2018
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY APPLICATION, 2013-2018
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY APPLICATION, 2013-2018
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE (%), BY END USER, 2013-2018
  • TABLE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION), BY END USER, 2013-2018
  • TABLE KEY SUPPLIERS OF RAW MATERIALS

List of Figures

  • FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY PRODUCT TYPE, 2017
  • FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY APPLICATION, 2017
  • FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE, BY END USER, 2017
  • FIGURE NORTH AMERICA OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
  • FIGURE EUROPE OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
  • FIGURE ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
  • FIGURE LATIN AMERICA OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
  • FIGURE MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
  • FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET ($MILLION), 2013-2025
  • FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE ANALYIS OF TOP 3 MANUFACTURERS
  • FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET SHARE ANALYIS OF TOP 5 MANUFACTURERS
  • FIGURE NORTH AMERICA OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
  • FIGURE EUROPE OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
  • FIGURE ASIA-PACIFIC OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
  • FIGURE LATIN AMERICA OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
  • FIGURE MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY SALES REVENUE ($MILLION), 2013-2018
  • FIGURE EYE DROPS SALES REVENUE ($MILLION), 2013-2018
  • FIGURE INTRAVITREAL INJECTIONS SALES REVENUE ($MILLION), 2013-2018
  • FIGURE OCULAR INSERTS SALES REVENUE ($MILLION), 2013-2018
  • FIGURE INTRAOCULAR IMPLANTS SALES REVENUE ($MILLION), 2013-2018
  • FIGURE IN SITU GELS SALES REVENUE ($MILLION), 2013-2018
  • FIGURE OTHER OCULAR DRUG DELIVERY PRODUCTS SALES REVENUE ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR GLAUCOMA ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR DIABETIC RETINOPATHY & MACULAR EDEMA ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR CATARACT ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR DRY EYE SYNDROME ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR MACULAR DEGENERATION ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER APPLICATIONS ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR HOSPITALS ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR HOMECARE SETTINGS ($MILLION), 2013-2018
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE FOR OTHER END USER ($MILLION), 2013-2018
  • FIGURE PROCESS ANALYSIS OF OCULAR DRUG DELIVERY
  • FIGURE INDUSTRIAL CHAIN ANALYSIS OF OCULAR DRUG DELIVERY MARKET
  • FIGURE GLOBAL OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE NORTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE EUROPE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE SOUTH AMERICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE EYE DROPS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE INTRAVITREAL INJECTIONS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE OCULAR INSERTS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE INTRAOCULAR IMPLANTS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE IN SITU GELS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE OTHER OCULAR DRUG DELIVERY PRODUCTS MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%), 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR GLAUCOMA, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR DIABETIC RETINOPATHY & MACULAR EDEMA, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR CATARACT, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR DRY EYE SYNDROME, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR MACULAR DEGENERATION, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR OTHER APPLICATIONS, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR HOSPITALS, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR HOMECARE SETTINGS, 2018-2025
  • FIGURE OCULAR DRUG DELIVERY MARKET REVENUE ($MILLION) FORECAST AND GROWTH RATE (%) FOR OTHER END USER, 2018-2025
Back to Top